The usefulness of immunohistochemistry in tissue microarrays of Human Papillomavirus negative adenocarcinoma of the uterine cervix

BMC Research Notes

Volumn 3, Issue , 2010, Pages

  Odida, Michael ^a,b   Lloveras, Belen ^c,d   Guimera, Nuria ^c   Weiderpass, Elisabete ^a,e,f,g  

^a KAROLINSKA INSTITUTE   (Sweden)

^b MAKERERE UNIVERSITY   (Uganda)

^c Institut Catal d' Oncologia   (Spain)

^d HOSPITAL DEL MAR   (Spain)

^e Cancer Registry of Norway ^*  (Norway)

^f UNIVERSITY OF TROMSØ   (Norway)

^g FOLKHÄLSAN RESEARCH CENTER   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN PAPILLOMAVIRUS;

EID: 77951151395     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-3-54     Document Type: Article

References (18)

1. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. JM Walboomers MV Jacobs MM Manos FX Bosch JA Kummer KV Shah PJ Snijders J Peto CJ Meijer N Mũoz, J Pathol 1999 189 1 12 19 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F 10451482 (Pubitemid 29406813)
2. Human papillomavirus and cervical cancer - burden and assessment of causality. FX Bosch S de Sanjose, J Natl Cancer Inst Monogr 2003 31 3 13 12807939 (Pubitemid 36159887)
3. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. X Castellsague M Diaz S de Sanjose N Munoz R Herrero S Franceschi RW Peeling R Ashley JS Smith PJ Snijders, et al. J Natl Cancer Inst 2006 98 303 315 16507827
4. Immunohistochemistry as a diagnostic aid in cervical pathology. WG McCluggage, Pathology 2007 39 1 97 111 10.1080/00313020601123961 17365826 (Pubitemid 46310782)
5. Immunophenotypic diversity of endometrial adenocarcinomas: implications for differential diagnosis. M Reid-Nicholson P Iyengar AJ Hummer I Linkov M Asher RA Soslow, Mod Pathol 2006 19 8 1091 1100 16648864 (Pubitemid 44106724)
6. A panel of immunohistochemical stains, including carcinoembryonic antigen, vimentin, and estrogen receptor, aids the distinction between primary endometrial and endocervical adenocarcinomas. WG McCluggage VP Sumathi HA McBride A Patterson, Int J Gynecol Pathol 2002 21 1 11 15 10.1097/00004347- 200201000-00003 11781517 (Pubitemid 34008347)
7. Immunohistochemical staining in the distinction between primary endometrial and endocervical adenocarcinomas: another viewpoint. S Kamoi MI AlJuboury MR Akin SG Silverberg, Int J Gynecol Pathol 2002 21 3 217 223 10.1097/00004347-200207000-00003 12068166
8. The value of HPV DNA typing in the distinction between adenocarcinoma of endocervical and endometrial origin. M Plunkett B Brestovac J Thompson G Sterrett P Filion D Smith F Frost, Pathology 2003 35 5 397 401 10.1080/00313020310001602611 14555383
9. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor. A Yemelyanova R Vang JD Seidman PE Gravitt BM Ronnett, Am J Surg Pathol 2009 33 6 914 924 10.1097/PAS. 0b013e3181971fdd 19295407
10. Overexpression of p16INK4A as an indicator for human papillomavirus oncogenic activity in cervical squamous neoplasia. M Ishikawa T Fujii M Saito I Nindl A Ono K Kubushiro K Tsukazaki M Mukai S Nozawa, Int J Gynecol Cancer 2006 16 347 353 10.1111/j.1525-1438.2006.00355.x 16445657
11. Novel short-fragment PCR assay for highly sensitive broadspectrum detection of anogenital human papillomaviruses. B Kleter LJ van Doorn J ter Schegget L Schrauwen K van Krimpen M Burger B ter Harmsel W Quint, Am J Pathol 1998 153 1731 1739 9846964
12. Human Papillomavirus type distribution in invasive cervical cancer in Uganda. M Odida S de Sanjosé W Quint FX Bosch J Klaustermeier E Weiderpass, BMC Infectious Diseases 2008 8 85
13. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas. R Vang AM Gown M Farinola TS Barry DT Wheeler A Yemelyanova JD Seidman K Judson BM Ronnett, Am J Surg Pathol 2007 31 5 653 663 10.1097/01.pas.0000213369.71676.25 17460447
14. HPV Type Distribution In Invasive Cervical Cancer: The Worldwide Perspective. S de Sanjose W Quint J Klaustermeier B Lloveras JP Brunsveld R Font N Guimera S Garland A Nessa YL Qiao, et al. Abstract Book. 24th International Papillomavirus Conference and Clinical Workshop: 3rd to 9th November 2007; Beijing, China 2007
15. Expression of cyclindependent kinase inhibitors p16MTS1, p21WAF1, and p27KIP1 in HPV-positive and HPV-negative cervical adenocarcinomas. K Milde-Langosch S Reithdorf A Kraws-Poppinghaus, Virchows Arch 2001 439 55 61 10.1007/s004280100439 11499840
16. Correlation of p16 and pRb expression with HPV detection in Bowen's disease. JH Willman D Heinz LE Golitz KR Shroyer, J Cutan Pathol 2006 33 629 633 10.1111/j.1600-0560.2006.00499.x 16965338
17. Immunoprofile of cervical and endometrial adenocarcinomas using a tissue microarray. A Alkushi J Irving F Hsu B Dupuis C Liu M Rijn CB Gilks, Virchows Arch 2003 442 3 271 277 12647218
18. Immunohistochemical characterization of endocervical papillary serous carcinoma. S Nofech-Mozes G Rasty N Ismiil A Covens MA Khalifa, Int J Gynecol Cancer 2006 16 Suppl 1 286 292 10.1111/j.1525-1438.2006.00514.x 16515605